# ANI Pharmaceuticals (ANIP) — Overview

ANIP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/anip

## Price

Last close $72.28 on Oct 15, 2026. 52-week range $70.16 – $95.38.

## Company profile

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $978.4M |
| Revenue (quarter) | $266.0M |
| Revenue growth (year over year) | 25.87% |
| Gross profit (trailing twelve months) | $591.0M |
| Gross margin | 60.40% |
| Net income (trailing twelve months) | $108.3M |
| Net income (quarter) | $24.7M |
| Net income growth (year over year) | 189.05% |
| Net margin | 11.07% |
| Return on equity | 20.88% |
| EPS (trailing twelve months) | $4.83 |
| Book value per share | $26.01 |
| P/E (trailing twelve months) | 15.4 |
| Price to book | 2.8 |
| Debt to assets | 60.03% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is ANI Pharmaceuticals (ANIP) profitable?

Yes. ANI Pharmaceuticals earned $108.3M in net income over the trailing twelve months, a net margin of 11.07%.

### How much revenue does ANI Pharmaceuticals (ANIP) make?

ANI Pharmaceuticals generated $978.4M in revenue over the trailing twelve months, up 25.87% year over year.

### What is ANIP's P/E ratio?

ANI Pharmaceuticals trades at 15.4 times trailing twelve-month earnings, on an EPS of $4.83.

### How do I buy stock in ANI Pharmaceuticals (ANIP)?

ANIP trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock
- [ANVS](https://www.lighthorse.io/tickers/anvs) — Annovis Bio, Inc. Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).